Efficacy and Safety of LY01005 in Patients With Prostate Cancer Compared to ZOLADEX®
Clinical trial NCT04563936 · COMPLETED
Trial details
- NCT number
- NCT04563936
- Sponsor
- Luye Pharma Group Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-06
- Primary completion
- 2021-03-09
- Enrollment
- 290
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.